Clinical TrialID 3736

Topical Perillyl Alcohol in Treating Patients With Sun Damaged Skin and Actinic Keratoses

NCT00608634

Precancerous Condition

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
3736
Evidence Id
3736
Core Evidence Id
3736
Source Clinical Trial Id
3709
Herb2 Clinical Trial Id
HBCT003709
Nct Id
NCT00608634
Title
Topical Perillyl Alcohol in Treating Patients With Sun Damaged Skin and Actinic Keratoses
Status
Completed
Phase
Phase 2
Study Result
Yes
Study Condition
Precancerous Condition
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Intervention
DRUG: perillyl alcohol|OTHER: placebo
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Quadruple
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
89
Outcome Measure
Change in Histopathology Score of Sun Damaged Skin by Treatment Group, The histopathologic scoring for skin biopsies from sun-damaged skin to assess the following seven characteristics: 1- atypia (levels 0, 1 \& 2), 2- inflammation (grades 0, 1 \& 2), 3- hyperkeratosis (loss of basket weave pattern of stratum corneum), 4- parakeratosis (present when there were \>3 characteristic nuclei per 40:1 field in stratum corneum), 5- dyskeratosis (focal presence of cells with homogenous, pink cytoplasm n pyknotic nuclei), 6- epidermotropism (lymphocytes migration of \>3 cells into epidermis, 7- loss of granular layer. All assessments were done using a 40:1 objective., Baseline to 3 months
Sponsor Collaborator
University of Arizona|National Cancer Institute (NCI)|Arizona Disease Control Research Commission
Funded By
OTHER
Location
Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, 85724-5024, United States
Other Id
CDR0000582634|P01CA027502|P30CA023074|UARIZ-HSC-04-27|UARIZ-POH-002
Start Date
2004-05
Primary Completion Date
2008-06
Completion Date
2009-06
First Posted
2008-02-06
Results First Posted
2015-04-01
Last Update Posted
2015-04-01
Study Document
Study Url
https://clinicaltrials.gov/study/NCT00608634
Title Cn
Title En
Topical Perillyl Alcohol in Treating Patients With Sun Damaged Skin and Actinic Keratoses
Bilingual Status
semi_complete